US Bancorp DE Buys 144 Shares of Humana Inc. (NYSE:HUM)

US Bancorp DE increased its stake in Humana Inc. (NYSE:HUM) by 0.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 28,459 shares of the insurance provider’s stock after acquiring an additional 144 shares during the period. US Bancorp DE’s holdings in Humana were worth $7,220,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of HUM. Creative Financial Designs Inc. ADV raised its position in shares of Humana by 244.0% during the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 61 shares during the last quarter. Janney Montgomery Scott LLC increased its position in Humana by 11.6% in the third quarter. Janney Montgomery Scott LLC now owns 3,721 shares of the insurance provider’s stock worth $1,179,000 after purchasing an additional 388 shares during the period. Van ECK Associates Corp bought a new stake in Humana during the 3rd quarter worth about $424,000. Robeco Institutional Asset Management B.V. lifted its position in Humana by 44.7% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 11,162 shares of the insurance provider’s stock valued at $3,535,000 after purchasing an additional 3,447 shares during the period. Finally, Intact Investment Management Inc. boosted its stake in shares of Humana by 46.3% in the 3rd quarter. Intact Investment Management Inc. now owns 2,780 shares of the insurance provider’s stock valued at $881,000 after purchasing an additional 880 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. Bank of America raised shares of Humana from an “underperform” rating to a “neutral” rating and boosted their price target for the stock from $247.00 to $308.00 in a research note on Wednesday, November 6th. Barclays upped their target price on shares of Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a research report on Thursday, February 13th. StockNews.com downgraded Humana from a “buy” rating to a “hold” rating in a research note on Wednesday. Truist Financial lifted their price objective on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research note on Monday, January 6th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $283.00 target price on shares of Humana in a research note on Wednesday, February 12th. Twenty investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $285.68.

Humana Price Performance

Shares of NYSE HUM opened at $263.74 on Wednesday. The company has a fifty day moving average price of $271.40 and a 200 day moving average price of $285.08. The firm has a market cap of $31.82 billion, a PE ratio of 26.51, a PEG ratio of 2.05 and a beta of 0.57. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46.

Humana (NYSE:HUM) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Research analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.34%. Humana’s dividend payout ratio (DPR) is presently 35.58%.

Insider Transactions at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.32% of the stock is currently owned by insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.